SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001593034-21-000101
Filing Date
2021-11-05
Accepted
2021-11-05 11:42:12
Documents
100
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q endp-20210930.htm   iXBRL 10-Q 2568146
2 EX-31.1 a20210930ex311ceo302cert.htm EX-31.1 8684
3 EX-31.2 a20210930ex312cfo302cert.htm EX-31.2 8701
4 EX-32.1 a20210930ex321ceo906cert.htm EX-32.1 6154
5 EX-32.2 a20210930ex322cfo906cert.htm EX-32.2 6183
  Complete submission text file 0001593034-21-000101.txt   12610271

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT endp-20210930.xsd EX-101.SCH 80675
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT endp-20210930_cal.xml EX-101.CAL 98342
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT endp-20210930_def.xml EX-101.DEF 385116
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT endp-20210930_lab.xml EX-101.LAB 850473
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT endp-20210930_pre.xml EX-101.PRE 603047
11 EXTRACTED XBRL INSTANCE DOCUMENT endp-20210930_htm.xml XML 2780424
Mailing Address MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE DUBLIN 4 L2 00000
Business Address MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE DUBLIN 4 L2 00000 353-1-268-2000
Endo International plc (Filer) CIK: 0001593034 (see all company filings)

IRS No.: 680683755 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36326 | Film No.: 211383227
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences